Showing results (31-40 of 159) with videos related to
Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Challenging BRAF/EGFR co-inhibition in NSCLC using sequential liquid biopsiesJ Solassol, J A Vendrell, R Senal, et al.Revue Des Maladies Respiratoires|March 10, 2007
[The contribution of cognitive-behavioural therapies to smoking cessation]P Guichenez, I Clauzel, C Cungi, et al.Presse Medicale (Paris, France : 1983)|March 9, 1991
[Neoadjuvant chemotherapy of non-small cell bronchial cancers]J L Pujol, F B MichelRevue Des Maladies Respiratoires|April 23, 2014
[One more word about the diagnostic. A metapsychological approach]J-L Pujol, J-P MérelBulletin De L'Academie Nationale De Medecine|October 1, 1996
[Bronchial cancer: from epidemiology to treatment]F B Michel, J L PujolCritical Reviews in Oncology/Hematology|October 26, 2011
Adjuvant early breast cancer systemic therapies according to daily used technologiesW Jacot, M Gutowski, D Azria, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatinJ-L Pujol, J-L Breton, R Gervais, et al.Pathologie-Biologie|June 2, 2009
[Anti-HER2 vaccines: The HER2 immunotargeting future?]M Z Ladjemi, W Jacot, A Pèlegrin, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 1995
Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSFV Gautier, J L Pujol, F B MichelBritish Journal of Cancer|July 7, 2000
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agentJ L Pujol, L Carestia, J P DaurèsPageof 16